Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O. M. Kostareva"'
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 289-293 (2019)
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are the most common autoimmune rheumatic diseases (RD) that occur mostly in women of childbearing age, and the occurrence of pregnancy is an expected fact. Due to the ongoing disputes o
Externí odkaz:
https://doaj.org/article/00acd30e661c48e4bbb64368ac15c77b
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 2, Pp 229-234 (2019)
Objective: to assess the possibility of using varying interval between intravenous infusions of tocilizumab (TCZ) as a tool for choosing the optimal treatment regimen in systemic juvenile arthritis (SJA).Subjects and methods. The observational retros
Externí odkaz:
https://doaj.org/article/9244cf1553084752bc7baf6e0d420755
Autor:
I. P. Nikishina, O. M. Kostareva
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 2, Pp 138-143 (2018)
The undeniable progress made over the last decade in the treatment of patients with severe juvenile arthritis has ranked in the order of priorities for the provision of efficient and reliable continuity in the management tactics for patients after th
Externí odkaz:
https://doaj.org/article/5e6535b015a34ad281fe1cf4c7c7988d
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 6, Pp 662-667 (2018)
Tocilizumab (TCZ) is one of the biological agents that are most commonly used in the treatment of juvenile idiopathic arthritis (JIA), especially its systemic variant. The development of neutropenia, which is associated with the use of TCZ and its me
Externí odkaz:
https://doaj.org/article/d0059567bfd04f8590e705d3b3ac3daa
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 6, Pp 662-667 (2018)
Tocilizumab (TCZ) is one of the biological agents that are most commonly used in the treatment of juvenile idiopathic arthritis (JIA), especially its systemic variant. The development of neutropenia, which is associated with the use of TCZ and its me